18,587 articles
Peter R. Orszag
Peter R. Orszag, American economist; CEO and Chairman of Lazard since October 2023; former Director of the Congressional Budget Office (2007-2008) and OMB Director under Obama; health care cost policy specialist.
Peter Reddien
Peter Reddien, born 1974, is an American biologist who is a Howard Hughes Medical Institute Investigator and studies how planarian flatworms regrow missing body parts using stem cells.
Peter Rehling
Peter Rehling (born 1966) is a German biochemist who has led the Institute of Cellular Biochemistry at the University Medical Center Göttingen since 2007, known for work on mitochondrial protein import and respiratory-chain assembly.
Peter Reichard
Peter Reichard (1925–2018) was a Swedish biochemist and Karolinska Institutet professor best known for discovering ribonucleotide reductase, the enzyme that supplies the four building blocks of DNA.
Peter Rona (physician)
Peter Rona, born Peter Rosenfeld, was a physician and biochemist who led the Charité's chemical department in Berlin, published about 200 papers, and was nominated for the 1925 Nobel Prize.
Peter Rossing
Peter Rossing (born 1965) is a Danish physician and medical researcher in endocrinology and diabetes, known for research on diabetic kidney disease and co-chairing the KDIGO 2022 guideline.
Peter Rothwell
Peter M. Rothwell is a British clinical neurologist and Professor of Clinical Neurology at the University of Oxford, known for stroke prevention research and the EXPRESS study.
Peter Rotwein
Peter Rotwein is an American physician-scientist in endocrinology and biochemistry known for work on insulin-like growth factors and early studies linking insulin-gene variation to type 2 diabetes.
Peter S. Klein
Peter S. Klein is a physician-scientist at the University of Pennsylvania who studies GSK-3, Wnt signaling, and hematopoietic stem cells, and showed lithium blocks amyloid-β production.
Peter S. Linsley
Peter S. Linsley is an American immunologist who showed that CTLA-4 is a second receptor for B7 and developed CTLA4Ig, which became the drug abatacept.
Peter S. McPherson
Peter S. McPherson is a Canadian neuroscientist at McGill University's Montreal Neurological Institute who identified key proteins in clathrin-mediated endocytosis and linked membrane trafficking to ataxia, ALS, and epilepsy.
Peter S. Nelson
Peter S. Nelson is an American medical oncologist and cancer genomics researcher at Fred Hutch Cancer Center in Seattle, specializing in inherited risk for advanced prostate cancer.
Peter Salama
Peter Salama (1968–2020) was an Australian medical epidemiologist who led the World Health Organization's Health Emergencies Programme from 2016 to 2019 after a career with UNICEF and the CDC.
Peter Sandercock
Peter Sandercock is a neurologist and Emeritus Professor of Medical Neurology at the University of Edinburgh who led the International Stroke Trial and its successor, IST-3.
Peter Sarnow
Peter Sarnow is a molecular biologist and Stanford professor known for work on the hepatitis C virus IRES and for identifying the liver microRNA miR-122 as essential for HCV replication.
Peter Sasieni
Peter Sasieni is a British cancer epidemiologist and biostatistician, Professor at Queen Mary University of London, whose research reshaped NHS cervical screening and quantified HPV vaccination's impact.
Peter Schmid (medical oncologist)
Peter Schmid is a British-based medical oncologist specializing in breast cancer, who leads the Centre for Experimental Cancer Medicine at Barts Cancer Institute in London.
Peter Schuster (Austrian chemist)
Peter Schuster (1941–2026) was an Austrian theoretical chemist who, with Manfred Eigen, developed the quasispecies and hypercycle models and the ViennaRNA package, and pioneered RNA sequence–structure maps.
Peter Shaw Ashton
Peter Shaw Ashton (born 1934) is a British botanist and tropical forest ecologist, a world authority on the Dipterocarpaceae, who co-founded the Smithsonian forest-plot network CTFS.
Peter Simmonds
Peter Simmonds is a virologist known for his work on the evolution and taxonomy of human viruses, especially hepatitis C virus, and is now Visiting Professor at the University of Turku.
Peter Sleight
Peter Sleight (1929–2020) was a British cardiologist, the first Field-Marshal Alexander Professor of Cardiovascular Medicine at Oxford, who chaired the ISIS trials recruiting about 140,000 patients.
Péter Somogyi
Péter Somogyi, born in Hungary in 1950, is a Hungarian-British neurobiologist and Emeritus Professor at Oxford known for classifying hippocampal interneurons and winning the 2011 Brain Prize.
Peter St George‐Hyslop
Peter St George-Hyslop (born 1953) is a Canadian neurologist and molecular geneticist known for identifying the presenilin genes that cause early-onset familial Alzheimer's disease, and a Fellow of the Royal Society.
Peter Starlinger
Peter Starlinger (1931–2017) was a German geneticist and molecular biologist at the University of Cologne whose group sequenced McClintock's maize transposable elements Ac and Ds in the 1980s.
Peter Sterling (neuroscientist)
Peter Sterling (born 1940) is an American neuroscientist, professor at the University of Pennsylvania, who pioneered 3D electron-microscopic reconstruction of retinal circuits and developed allostasis.
Peter Strick
Peter L. Strick is an American systems neuroscientist at the University of Pittsburgh who maps brain circuits controlling movement and organs, and was elected to the National Academy of Sciences in 2012.
Peter T. Lansbury
Peter T. Lansbury, also known as Peter Lansbury, is an American chemist turned neurodegeneration researcher, professor of neurology at Harvard Medical School, and founder of Link Medicine.
Peter T. Macklem
Peter T. Macklem (1931–2011) was a Canadian respiratory physician-scientist at McGill University in Montreal, known for work on small airways disease and respiratory muscle fatigue.
Peter ten Dijke
Peter ten Dijke is a Dutch molecular cell biologist known for work on TGF-β signaling and SMAD proteins, and professor of molecular cell biology at Leiden University Medical Center.
Peter Tontonoz
Peter Tontonoz is an American physician-scientist and Distinguished Professor at UCLA who studies cholesterol and lipid metabolism, known for the LXR, PPAR, IDOL, and Aster protein discoveries.